Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for P50395

Entry ID Method Resolution Chain Position Source
AF-P50395-F1 Predicted AlphaFoldDB

273 variants for P50395

Variant ID(s) Position Change Description Diseaes Association Provenance
rs1260751824
CA375901422
4 E>D No ClinGen
TOPMed
rs543226756
CA5395468
4 E>Q No ClinGen
1000Genomes
ExAC
gnomAD
CA5395465
rs762509646
6 D>E No ClinGen
ExAC
gnomAD
rs763560240
CA5395466
6 D>H No ClinGen
ExAC
gnomAD
TCGA novel 6 D>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA5395464
rs376740115
8 I>V No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA5395462
rs759415310
15 T>M No ClinGen
ExAC
gnomAD
rs1016814314
CA202285933
16 E>V No ClinGen
TOPMed
CA375921327
rs1172602595
17 C>Y No ClinGen
gnomAD
CA202285929
rs966219982
22 I>V No ClinGen
TOPMed
gnomAD
CA5395427
rs780596758
23 M>K No ClinGen
ExAC
CA5395426
rs11557445
27 G>D No ClinGen
ExAC
TOPMed
gnomAD
CA5395424
rs777303485
28 K>R No ClinGen
ExAC
gnomAD
CA5395423
rs758016791
29 K>N No ClinGen
ExAC
CA5395422
rs752282460
30 V>I No ClinGen
ExAC
gnomAD
rs1202362843
CA375921237
31 L>R No ClinGen
gnomAD
rs764877548
CA5395421
33 M>V No ClinGen
ExAC
TOPMed
gnomAD
CA5395420
rs148812584
35 R>Q No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA375921198
rs1564398174
37 P>S No ClinGen
Ensembl
rs767665480
CA5395415
43 S>G No ClinGen
ExAC
gnomAD
rs142565898
CA5395414
44 A>V No ClinGen
ESP
ExAC
gnomAD
CA375921135
rs1360206840
46 I>M No ClinGen
gnomAD
CA5395413
rs200426511
46 I>V No ClinGen
ExAC
TOPMed
gnomAD
rs768783267
CA5395412
47 T>I No ClinGen
ExAC
rs775865227
CA5395410
51 D>G No ClinGen
ExAC
TOPMed
gnomAD
rs1232013589
CA375921083
52 L>F No ClinGen
gnomAD
rs1342883333
CA375921073
54 K>E No ClinGen
gnomAD
CA202283703
rs1019275062
57 K>T No ClinGen
TOPMed
gnomAD
CA375921033
rs1400051006
59 P>L No ClinGen
TOPMed
gnomAD
CA375921035
rs1400051006
59 P>R No ClinGen
TOPMed
gnomAD
rs768378594
CA5395383
59 P>T No ClinGen
ExAC
gnomAD
rs748784089
CA5395382
60 G>E No ClinGen
ExAC
TOPMed
gnomAD
CA375921014
rs1430603676
63 P>A No ClinGen
gnomAD
rs755557916
CA5395380
64 E>K No ClinGen
ExAC
TOPMed
gnomAD
rs1350264115
CA375920989
66 M>I No ClinGen
gnomAD
COSM3769141
CA375920995
rs1161274879
66 M>V pancreas [Cosmic] No ClinGen
cosmic curated
TOPMed
CA5395378
rs781104500
70 R>K No ClinGen
ExAC
gnomAD
CA5395376
CA5395377
rs751297603
71 D>E No ClinGen
ExAC
gnomAD
rs752826771
CA5395373
80 F>S No ClinGen
ExAC
gnomAD
rs1028430226
CA202283652
84 N>S No ClinGen
TOPMed
CA375920836
rs1209851717
86 Q>H No ClinGen
TOPMed
rs200939621
CA5395356
90 M>I No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs757136543
CA5395357
90 M>T No ClinGen
ExAC
TOPMed
gnomAD
CA375920801
rs1302082156
92 L>F No ClinGen
gnomAD
rs777580570
CA5395355
94 T>I No ClinGen
ExAC
gnomAD
rs758102346
CA5395354
95 E>K No ClinGen
ExAC
gnomAD
TCGA novel 98 R>H Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA5395352
rs765371059
99 Y>H No ClinGen
ExAC
gnomAD
CA5395350
rs753922992
111 Y>C No ClinGen
ExAC
TOPMed
gnomAD
rs202121128
CA5395349
113 G>D No ClinGen
1000Genomes
ExAC
gnomAD
rs1045254840
CA202282519
113 G>R No ClinGen
Ensembl
CA375920655
rs202121128
113 G>V No ClinGen
1000Genomes
ExAC
gnomAD
CA202282513
rs868111616
115 K>E No ClinGen
Ensembl
rs761309123
CA5395348
116 I>T No ClinGen
ExAC
gnomAD
CA375920631
rs1201007910
117 Y>C No ClinGen
TOPMed
gnomAD
rs1441692245
CA375920618
119 V>L No ClinGen
gnomAD
CA5395346
rs768053339
122 T>A No ClinGen
ExAC
gnomAD
rs762081303
CA5395345
124 A>T No ClinGen
ExAC
gnomAD
CA375920565
rs1419856871
127 L>R No ClinGen
TOPMed
CA5395343
rs769270716
129 S>C No ClinGen
ExAC
gnomAD
rs770482276
CA5395321
132 M>L No ClinGen
ExAC
gnomAD
rs1233659497
CA375920505
135 F>L No ClinGen
gnomAD
rs1478556769
CA375920493
136 E>V No ClinGen
Ensembl
CA375920480
rs1354631339
138 R>C Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs1271271901
CA375920479
138 R>H Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs372911228
CA5395320
139 R>C No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs376781352
CA5395319
139 R>H Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
TCGA novel
CA375920448
rs1341150715
143 F>L Variant assessed as Somatic; impact. Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No NCI-TCGA
ClinGen
gnomAD
CA5395318
rs562861312
144 L>V No ClinGen
1000Genomes
ExAC
gnomAD
rs1393500613
CA375920433
145 V>A No ClinGen
gnomAD
CA375920427
rs1306956229
146 Y>C No ClinGen
TOPMed
CA375920426
rs1306956229
146 Y>F No ClinGen
TOPMed
rs573927164
CA5395315
149 N>S No ClinGen
1000Genomes
ExAC
gnomAD
CA375920398
rs140194178
150 F>L No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA202277355
rs866985835
151 D>G No ClinGen
gnomAD
CA202277358
rs151315864
151 D>H No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs151315864
CA5395313
151 D>N No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs756268782
CA5395312
152 E>Q No ClinGen
ExAC
TOPMed
gnomAD
CA375920383
rs1191836063
153 K>E No ClinGen
gnomAD
CA375920379
rs1403706378
153 K>I No ClinGen
TOPMed
gnomAD
rs781732850
CA5395310
154 D>G No ClinGen
ExAC
gnomAD
rs750474960
CA375920375
154 D>N No ClinGen
ExAC
gnomAD
TCGA novel 154 D>R Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs750474960
CA5395311
154 D>Y Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA375920370
rs1344301823
155 P>T No ClinGen
TOPMed
gnomAD
rs202191827
CA5395309
156 R>K No ClinGen
ExAC
TOPMed
gnomAD
rs1271055372
CA375920346
158 F>L No ClinGen
gnomAD
CA202277336
rs372503635
158 F>S No ClinGen
ESP
CA5395308
rs752074817
160 G>R No ClinGen
ExAC
gnomAD
CA5395307
rs764410675
161 I>T No ClinGen
ExAC
TOPMed
gnomAD
rs1269891905
CA375920331
161 I>V No ClinGen
gnomAD
rs763287706
CA5395306
163 P>S No ClinGen
ExAC
gnomAD
rs369540308
CA202277326
164 K>E No ClinGen
ESP
TCGA novel 165 K>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA202277324
rs201031883
166 T>A No ClinGen
1000Genomes
CA202277322
rs11557447
166 T>N No ClinGen
gnomAD
rs201917946
CA202277318
167 T>A No ClinGen
1000Genomes
rs765946289
CA5395304
168 M>V No ClinGen
ExAC
gnomAD
CA5395303
rs530025524
169 R>Q No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs77029930
CA5395302
173 K>R No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs1414834265
CA375920248
174 K>Q No ClinGen
gnomAD
CA5395300
rs761709460
177 L>V No ClinGen
ExAC
gnomAD
CA5395299
rs774331835
178 G>S No ClinGen
ExAC
TOPMed
gnomAD
CA5395296
rs770089565
180 D>E No ClinGen
ExAC
TOPMed
gnomAD
rs748807997
CA202277263
181 V>I Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
CA5395294
rs750753689
182 I>T No ClinGen
ExAC
gnomAD
rs1269478306
CA375920184
183 D>G No ClinGen
TOPMed
CA375920135
rs1272522143
190 A>G No ClinGen
TOPMed
gnomAD
CA375920134
rs1272522143
190 A>V No ClinGen
TOPMed
gnomAD
CA5395291
rs752060178
191 L>V No ClinGen
ExAC
rs983927598
CA202277241
192 Y>H No ClinGen
TOPMed
CA375920108
rs1290080550
195 D>N No ClinGen
TOPMed
CA375920051
rs1444346776
200 Q>H No ClinGen
gnomAD
CA5395279
rs775383329
201 P>L Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
CA375920040
rs1345876246
202 C>Y Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA375920032
rs1312054264
203 Y>C No ClinGen
TOPMed
gnomAD
CA375920031
rs1312054264
203 Y>F No ClinGen
TOPMed
gnomAD
CA5395276
rs200329717
206 I>F No ClinGen
ExAC
gnomAD
rs770979438
CA5395275
207 N>D No ClinGen
ExAC
gnomAD
rs965162866
CA202276699
207 N>K No ClinGen
Ensembl
rs1376885667
CA375920006
207 N>S No ClinGen
gnomAD
rs747040286
CA5395274
209 I>V No ClinGen
ExAC
gnomAD
rs894369983
CA202276684
212 Y>C No ClinGen
TOPMed
TCGA novel 214 E>D Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs531926886
CA202276649
217 A>E No ClinGen
ExAC
gnomAD
rs531926886
CA5395271
217 A>G No ClinGen
ExAC
gnomAD
CA5395270
rs531926886
217 A>V No ClinGen
ExAC
gnomAD
TCGA novel 218 R>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1323493012
CA375919889
224 Y>C No ClinGen
TOPMed
gnomAD
rs1588975543
CA375919884
225 L>V No ClinGen
Ensembl
TCGA novel 227 P>Q Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1473688058
CA375919869
227 P>S No ClinGen
TOPMed
gnomAD
rs755326206
CA375919856
229 Y>C No ClinGen
ExAC
TOPMed
gnomAD
rs755326206
CA5395268
229 Y>F No ClinGen
ExAC
TOPMed
gnomAD
rs1288272219
CA375919819
235 P>S Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
TCGA novel 237 G>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA375919807
rs1209436921
237 G>R No ClinGen
TOPMed
TCGA novel 238 F>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs367780908
CA5395266
239 A>T No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA5395241
rs752744422
242 S>C No ClinGen
ExAC
TOPMed
gnomAD
rs139588848
CA5395239
244 I>L No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA5395238
rs139903550
245 Y>F No ClinGen
1000Genomes
ExAC
CA5395237
rs766059425
249 Y>C No ClinGen
ExAC
gnomAD
TCGA novel 252 N>D Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA5395236
rs761007931
254 P>H No ClinGen
ExAC
TOPMed
gnomAD
rs898906261
CA202264380
254 P>S No ClinGen
Ensembl
CA5395234
rs761818808
255 I>N No ClinGen
ExAC
gnomAD
rs761818808
CA5395233
255 I>T No ClinGen
ExAC
gnomAD
CA5395235
rs773410031
255 I>V No ClinGen
ExAC
TOPMed
gnomAD
rs1212194068
CA375919215
256 E>D No ClinGen
gnomAD
rs1588968275
CA375919205
257 E>G No ClinGen
Ensembl
CA5395232
rs368138033
258 I>M No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1016039023
CA202264355
258 I>V No ClinGen
TOPMed
gnomAD
TCGA novel 259 I>M Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1227744381
CA375919165
261 Q>* No ClinGen
gnomAD
CA202264348
rs1005120715
262 N>D No ClinGen
gnomAD
CA202264334
rs886241148
262 N>K No ClinGen
TOPMed
gnomAD
CA5395231
rs769161634
262 N>S No ClinGen
ExAC
gnomAD
TCGA novel 264 K>Q Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA5395230
rs749648480
267 G>C No ClinGen
ExAC
gnomAD
rs1325200627
CA375919096
268 V>I No ClinGen
gnomAD
rs780505114
CA5395229
269 K>E No ClinGen
ExAC
gnomAD
rs1398405386
CA375919040
273 E>Q No ClinGen
gnomAD
CA5395200
rs146005160
276 R>C No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs753880928
CA5395199
276 R>H No ClinGen
ExAC
TOPMed
gnomAD
CA375917958
rs753880928
276 R>L No ClinGen
ExAC
TOPMed
gnomAD
CA375917955
rs1426196359
277 C>S No ClinGen
TOPMed
CA375917940
rs1164690568
278 K>E No ClinGen
TOPMed
rs1293554962
CA375917900
281 I>T No ClinGen
TOPMed
TCGA novel 286 Y>C Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs767760359
CA5395195
287 V>I No ClinGen
ExAC
TOPMed
gnomAD
CA375917825
rs1406122912
288 K>Q No ClinGen
TOPMed
gnomAD
rs751756095
CA5395193
290 R>Q Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
rs533312902
CA5395194
290 R>W Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
1000Genomes
ExAC
NCI-TCGA
gnomAD
rs142508080
CA5395191
295 G>V No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1295308033
CA375917733
296 Q>* No ClinGen
gnomAD
rs776064987
CA5395190
296 Q>R No ClinGen
ExAC
gnomAD
rs765605235
CA5395189
300 V>F No ClinGen
ExAC
gnomAD
RCV000880990
rs138091745
CA5395188
303 I>V No ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
CA375917680
rs1265885616
304 L>F No ClinGen
TOPMed
rs1444395558
CA375917659
307 P>A No ClinGen
gnomAD
CA375917653
rs1249102287
308 I>V No ClinGen
gnomAD
CA375917643
rs1158541394
309 K>R No ClinGen
gnomAD
rs1452032255
CA375917636
310 N>T No ClinGen
gnomAD
CA202260150
rs150373325
311 T>S No ClinGen
ESP
rs151228905
CA5395185
312 N>S No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
TCGA novel 314 A>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA202260145
rs373728981
315 N>T No ClinGen
ESP
TOPMed
gnomAD
rs773872663
CA5395184
318 Q>H No ClinGen
ExAC
rs141174887
CA202260144
323 Q>* No ClinGen
ESP
rs1426033622
CA375917545
323 Q>H No ClinGen
TOPMed
rs1485203185
CA375917534
325 Q>E No ClinGen
gnomAD
CA5395183
rs369582201
325 Q>L No ClinGen
ESP
ExAC
CA375917522
rs1256451873
327 N>H No ClinGen
gnomAD
CA5395182
rs377006799
327 N>S No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1448273811
CA375917511
328 R>L No ClinGen
TOPMed
gnomAD
CA375917513
rs1448273811
328 R>Q Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
rs1262304833
CA375917501
330 S>P No ClinGen
gnomAD
CA375917479
rs1467901407
331 D>G No ClinGen
gnomAD
TCGA novel 333 Y>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs769275618
CA5395161
334 V>I No ClinGen
ExAC
TOPMed
gnomAD
rs769275618
CA375917460
334 V>L No ClinGen
ExAC
TOPMed
gnomAD
CA5395160
rs745861202
340 A>V No ClinGen
ExAC
TOPMed
gnomAD
rs1027231113
CA202258962
342 N>D No ClinGen
TOPMed
rs1269678060
CA375917401
342 N>S No ClinGen
TOPMed
gnomAD
CA375917379
rs1304869088
346 Q>E No ClinGen
gnomAD
rs778077425
CA5395156
347 G>A No ClinGen
ExAC
gnomAD
rs1424321511
CA375917348
350 I>N No ClinGen
TOPMed
gnomAD
CA5395154
rs752931374
350 I>V No ClinGen
ExAC
gnomAD
CA375917344
rs1411310272
351 A>T No ClinGen
gnomAD
CA375917339
rs1396504970
351 A>V No ClinGen
gnomAD
CA375917322
rs1391141347
354 S>N No ClinGen
TOPMed
gnomAD
CA5395153
rs765455596
356 T>A No ClinGen
ExAC
gnomAD
rs374026708
CA5395152
357 V>A No ClinGen
ESP
ExAC
gnomAD
rs767901615
CA202258944
358 E>K No ClinGen
Ensembl
CA5395150
rs766934973
364 K>N No ClinGen
ExAC
gnomAD
CA5395149
rs761124362
366 I>M No ClinGen
ExAC
TOPMed
gnomAD
rs1244782056
CA375917229
368 P>A No ClinGen
gnomAD
rs1244782056
CA375917228
368 P>S No ClinGen
gnomAD
CA375917208
rs1438606153
371 E>A No ClinGen
gnomAD
rs1206808947
CA375917210
371 E>Q No ClinGen
gnomAD
rs1203086435
CA375917186
374 E>A No ClinGen
gnomAD
rs201939478
CA202258931
374 E>K No ClinGen
gnomAD
CA375917173
rs1196601702
376 I>M No ClinGen
TOPMed
CA5395147
rs767896630
376 I>T No ClinGen
ExAC
TOPMed
gnomAD
CA5395148
rs750717677
376 I>V No ClinGen
ExAC
gnomAD
CA5395144
rs777840947
378 Q>H No ClinGen
ExAC
gnomAD
CA5395146
rs762565613
378 Q>P No ClinGen
ExAC
TOPMed
gnomAD
rs1217163523
CA375917137
379 K>N No ClinGen
gnomAD
CA375917154
rs1191198832
379 K>R No ClinGen
gnomAD
rs747920234
CA5395114
380 F>C No ClinGen
ExAC
TOPMed
gnomAD
CA5395113
rs779300230
381 V>G No ClinGen
ExAC
gnomAD
rs1588962379
CA375917115
382 S>I No ClinGen
Ensembl
COSM1603569
rs766972095
CA202258589
383 I>V liver [Cosmic] No ClinGen
cosmic curated
gnomAD
CA5395112
rs768960604
384 S>G No ClinGen
ExAC
gnomAD
CA202258567
rs201183386
387 L>P No ClinGen
1000Genomes
CA375917070
rs1293583657
388 V>I No ClinGen
gnomAD
rs1417112297
CA375917038
391 D>E No ClinGen
TOPMed
rs780334414
CA5395110
397 Q>H No ClinGen
ExAC
gnomAD
rs199531623
CA5395092
398 I>= Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
1000Genomes
ExAC
NCI-TCGA
TOPMed
gnomAD
rs1364347572
CA375916971
398 I>V No ClinGen
gnomAD
CA5395090
rs745900996
402 R>C No ClinGen
ExAC
TOPMed
gnomAD
rs781568391
CA5395089
402 R>H No ClinGen
ExAC
TOPMed
gnomAD
CA202258481
rs911503900
403 T>R No ClinGen
Ensembl
TCGA novel 411 E>Q Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1010582641
CA202258465
413 T>M Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
Ensembl
NCI-TCGA
rs758746730
CA5395082
417 I>V No ClinGen
ExAC
gnomAD
rs956483528
CA202258464
418 K>E No ClinGen
gnomAD
CA375916804
rs956483528
418 K>Q No ClinGen
gnomAD
CA5395081
rs753553466
420 I>M No ClinGen
ExAC
TOPMed
gnomAD
CA5395080
rs202024115
421 Y>C No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA5395079
rs202024115
421 Y>F No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA375916756
rs1267121616
423 R>S No ClinGen
gnomAD
CA5395078
rs749909436
428 E>K No ClinGen
ExAC
gnomAD
rs934554905
CA202258437
429 F>I No ClinGen
TOPMed
CA5395077
rs766907217
431 F>L No ClinGen
ExAC
gnomAD
rs1340890429
CA375916691
433 E>K No ClinGen
gnomAD
rs764049904
CA5395073
434 M>I No ClinGen
ExAC
gnomAD
CA5395074
rs774421940
434 M>V No ClinGen
ExAC
TOPMed
gnomAD
rs762772525
CA5395072
435 K>R No ClinGen
ExAC
gnomAD
CA5395071
rs368965101
436 R>C No ClinGen
ExAC
TOPMed
gnomAD
CA375916668
rs368965101
436 R>G No ClinGen
ExAC
TOPMed
gnomAD
rs745961164
CA5395069
436 R>H Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
CA5395070
rs745961164
436 R>P No ClinGen
ExAC
TOPMed
gnomAD
rs768266050 438 K>missing Variant assessed as Somatic; 0.0001884 impact. [NCI-TCGA] No NCI-TCGA
rs776809362
CA5395068
438 K>E No ClinGen
ExAC
gnomAD
rs1429145172
CA375916649
439 N>D No ClinGen
TOPMed
gnomAD
CA375916650
rs1429145172
439 N>H No ClinGen
TOPMed
gnomAD
CA375916632
rs1435883679
441 I>N No ClinGen
gnomAD
CA5395065
rs747573408
442 Y>C No ClinGen
ExAC
TOPMed
gnomAD
CA375916627
rs1377619541
442 Y>H No ClinGen
gnomAD
rs747573408
CA375916625
442 Y>S No ClinGen
ExAC
TOPMed
gnomAD
rs778246115
CA5395064
443 G>R No ClinGen
ExAC
TOPMed
gnomAD

No associated diseases with P50395

No regional properties for P50395

Type Name Position InterPro Accession
No domain, repeats, and functional sites for P50395

Functions

Description
EC Number
Subcellular Localization
  • Cytoplasm
  • Membrane ; Peripheral membrane protein
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

11 GO annotations of cellular component

Name Definition
azurophil granule lumen The volume enclosed by the membrane of an azurophil granule, a primary lysosomal granule found in neutrophil granulocytes that contains a wide range of hydrolytic enzymes and is released into the extracellular fluid.
cytoplasm The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
cytosol The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
extracellular exosome A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
extracellular region The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
focal adhesion A cell-substrate junction that anchors the cell to the extracellular matrix and that forms a point of termination of actin filaments. In insects focal adhesion has also been referred to as hemi-adherens junction (HAJ).
Golgi apparatus A membrane-bound cytoplasmic organelle of the endomembrane system that further processes the core oligosaccharides (e.g. N-glycans) added to proteins in the endoplasmic reticulum and packages them into membrane-bound vesicles. The Golgi apparatus operates at the intersection of the secretory, lysosomal, and endocytic pathways.
membrane A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
secretory granule lumen The volume enclosed by the membrane of a secretory granule.
synapse The junction between an axon of one neuron and a dendrite of another neuron, a muscle fiber or a glial cell. As the axon approaches the synapse it enlarges into a specialized structure, the presynaptic terminal bouton, which contains mitochondria and synaptic vesicles. At the tip of the terminal bouton is the presynaptic membrane; facing it, and separated from it by a minute cleft (the synaptic cleft) is a specialized area of membrane on the receiving cell, known as the postsynaptic membrane. In response to the arrival of nerve impulses, the presynaptic terminal bouton secretes molecules of neurotransmitters into the synaptic cleft. These diffuse across the cleft and transmit the signal to the postsynaptic membrane.
vesicle Any small, fluid-filled, spherical organelle enclosed by membrane.

4 GO annotations of molecular function

Name Definition
GTPase activator activity Binds to and increases the activity of a GTPase, an enzyme that catalyzes the hydrolysis of GTP.
Rab GDP-dissociation inhibitor activity Prevents the dissociation of GDP from the small GTPase Rab, thereby preventing GTP from binding.
RNA binding Binding to an RNA molecule or a portion thereof.
small GTPase binding Binding to a small monomeric GTPase.

6 GO annotations of biological process

Name Definition
negative regulation of cilium assembly Any process that stops, prevents or reduces the frequency, rate or extent of cilium assembly.
negative regulation of protein localization to cilium Any process that stops, prevents or reduces the frequency, rate or extent of protein localization to cilium.
protein transport The directed movement of proteins into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
signal transduction The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.
small GTPase mediated signal transduction The series of molecular signals in which a small monomeric GTPase relays a signal.
vesicle-mediated transport A cellular transport process in which transported substances are moved in membrane-bounded vesicles; transported substances are enclosed in the vesicle lumen or located in the vesicle membrane. The process begins with a step that directs a substance to the forming vesicle, and includes vesicle budding and coating. Vesicles are then targeted to, and fuse with, an acceptor membrane.

13 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
P39958 GDI1 Rab GDP-dissociation inhibitor Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast) PR
P21856 GDI1 Rab GDP dissociation inhibitor alpha Bos taurus (Bovine) PR
P50397 GDI2 Rab GDP dissociation inhibitor beta Bos taurus (Bovine) PR
P60028 GDI1 Rab GDP dissociation inhibitor alpha Pan troglodytes (Chimpanzee) PR
O97556 GDI2 Rab GDP dissociation inhibitor beta Canis lupus familiaris (Dog) (Canis familiaris) PR
P31150 GDI1 Rab GDP dissociation inhibitor alpha Homo sapiens (Human) PR
P50396 Gdi1 Rab GDP dissociation inhibitor alpha Mus musculus (Mouse) PR
Q61598 Gdi2 Rab GDP dissociation inhibitor beta Mus musculus (Mouse) PR
P50398 Gdi1 Rab GDP dissociation inhibitor alpha Rattus norvegicus (Rat) PR
P50399 Gdi2 Rab GDP dissociation inhibitor beta Rattus norvegicus (Rat) PR
Q9LXC0 At5g09550 Guanosine nucleotide diphosphate dissociation inhibitor At5g09550 Arabidopsis thaliana (Mouse-ear cress) PR
O24653 GDI2 Guanosine nucleotide diphosphate dissociation inhibitor 2 Arabidopsis thaliana (Mouse-ear cress) PR
Q96254 GDI1 Guanosine nucleotide diphosphate dissociation inhibitor 1 Arabidopsis thaliana (Mouse-ear cress) PR
10 20 30 40 50 60
MNEEYDVIVL GTGLTECILS GIMSVNGKKV LHMDRNPYYG GESASITPLE DLYKRFKIPG
70 80 90 100 110 120
SPPESMGRGR DWNVDLIPKF LMANGQLVKM LLYTEVTRYL DFKVTEGSFV YKGGKIYKVP
130 140 150 160 170 180
STEAEALASS LMGLFEKRRF RKFLVYVANF DEKDPRTFEG IDPKKTTMRD VYKKFDLGQD
190 200 210 220 230 240
VIDFTGHALA LYRTDDYLDQ PCYETINRIK LYSESLARYG KSPYLYPLYG LGELPQGFAR
250 260 270 280 290 300
LSAIYGGTYM LNKPIEEIIV QNGKVIGVKS EGEIARCKQL ICDPSYVKDR VEKVGQVIRV
310 320 330 340 350 360
ICILSHPIKN TNDANSCQII IPQNQVNRKS DIYVCMISFA HNVAAQGKYI AIVSTTVETK
370 380 390 400 410 420
EPEKEIRPAL ELLEPIEQKF VSISDLLVPK DLGTESQIFI SRTYDATTHF ETTCDDIKNI
430 440
YKRMTGSEFD FEEMKRKKND IYGED